Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T George

Showing results (721-730 of 771) with videos related to

Pageof 78
Sort By:
Clinical Kidney Journal|February 10, 2021
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
Journal of the American Heart Association|January 23, 2023
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 ResultsAndrea L Vavere, Marvin Sinsakul, Emily L Ongstad, et al.
Journal of Cardiovascular Computed Tomography|May 16, 2015
Combined coronary angiography and myocardial perfusion by computed tomography in the identification of flow-limiting stenosis - The CORE320 study: An integrated analysis of CT coronary angiography and myocardial perfusionTiago A Magalhães, Satoru Kishi, Richard T George, et al.
Molecular Psychiatry|May 19, 2010
A genetic determinant of the striatal dopamine response to alcohol in menV A Ramchandani, J Umhau, F J Pavon, et al.
Molecular Psychiatry|July 11, 2012
Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomographyJ Hirvonen, P Zanotti-Fregonara, J C Umhau, et al.
Circulation|December 28, 2018
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINADarren K McGuire, John H Alexander, Odd Erik Johansen, et al.
The American Journal of Cardiology|September 29, 2023
Combined Computed Tomography Angiography-Computed Tomography Perfusion in the Identification and Prognostic Assessment of Myocardial Bridging from the CORE320 Study: 5-Year Follow-UpMichael P Gannon, Rodrigo J Cerci, Carolina Valdiviezo, et al.
Cardiovascular Diabetology|March 16, 2018
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA<sup>®</sup>): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal riskJulio Rosenstock, Vlado Perkovic, John H Alexander, et al.
JACC. Cardiovascular Imaging|July 23, 2018
Comparative Effectiveness of CT-Derived Atherosclerotic Plaque Metrics for Predicting Myocardial IschemiaHooman Bakhshi, Zahra Meyghani, Satoru Kishi, et al.
Diabetes Care|May 24, 2020
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized TrialVlado Perkovic, Robert Toto, Mark E Cooper, et al.
Pageof 78

Showing results (721-730 of 771) with videos related to

Sort By:
Pageof 78
Clinical Kidney Journal|February 10, 2021
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
Journal of the American Heart Association|January 23, 2023
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 ResultsAndrea L Vavere, Marvin Sinsakul, Emily L Ongstad, et al.
Journal of Cardiovascular Computed Tomography|May 16, 2015
Combined coronary angiography and myocardial perfusion by computed tomography in the identification of flow-limiting stenosis - The CORE320 study: An integrated analysis of CT coronary angiography and myocardial perfusionTiago A Magalhães, Satoru Kishi, Richard T George, et al.
Molecular Psychiatry|May 19, 2010
A genetic determinant of the striatal dopamine response to alcohol in menV A Ramchandani, J Umhau, F J Pavon, et al.
Molecular Psychiatry|July 11, 2012
Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomographyJ Hirvonen, P Zanotti-Fregonara, J C Umhau, et al.
Circulation|December 28, 2018
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINADarren K McGuire, John H Alexander, Odd Erik Johansen, et al.
The American Journal of Cardiology|September 29, 2023
Combined Computed Tomography Angiography-Computed Tomography Perfusion in the Identification and Prognostic Assessment of Myocardial Bridging from the CORE320 Study: 5-Year Follow-UpMichael P Gannon, Rodrigo J Cerci, Carolina Valdiviezo, et al.
Cardiovascular Diabetology|March 16, 2018
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA<sup>®</sup>): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal riskJulio Rosenstock, Vlado Perkovic, John H Alexander, et al.
JACC. Cardiovascular Imaging|July 23, 2018
Comparative Effectiveness of CT-Derived Atherosclerotic Plaque Metrics for Predicting Myocardial IschemiaHooman Bakhshi, Zahra Meyghani, Satoru Kishi, et al.
Diabetes Care|May 24, 2020
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized TrialVlado Perkovic, Robert Toto, Mark E Cooper, et al.
Pageof 78